companydata.dkLEO PHARMA A/S: Financial statements 2020
CVR: 56759514
LEO PHARMA A/S (CVR 56759514) has filed annual accounts for 2020. In 2020, the company reported revenue of DKK 10,133,000,000 and a net result of DKK -951,000,000 compared with DKK -1,287,000,000 the year before. That is a decrease of 6.2% compared with the year before. The profit margin was -9.4%. Equity amounted to DKK 6,947,000,000. The solvency ratio was 29.1%.
- Revenue
- 10,133,000,000 kr.
- Gross Profit
- 6,773,000,000 kr.
- Profit/Loss
- -951,000,000 kr.
- Equity
- 6,947,000,000 kr.
- Total Assets
- 23,853,000,000 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | 10.1 mia. | 6.8 mia. | -951 mio. | 6.9 mia. | - |
| 2019 | 10.8 mia. | 7.5 mia. | -1.3 mia. | 8.1 mia. | - |
| 2018 | 10.4 mia. | 7.4 mia. | 1.3 mia. | 9.5 mia. | - |
| 2017 | 10.5 mia. | 7.5 mia. | 1.4 mia. | 8.3 mia. | - |
| 2016 | 7.4 mia. | 2.7 mia. | 743 mio. | 25.2 mia. | 5170 |
How creditworthy is LEO PHARMA A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
As of July 2, 2020, Rifat Ramicevic has joined the board of directors of LEO PHARMA A/S.
As of July 2, 2020, Laurids Bonne Bjørnshauge has left the board of directors of LEO PHARMA A/S.
LEO PHARMA A/S has published its annual report for 2019. Revenue came to DKK 10,805,000,000, and the net result was DKK -1,287,000,000.
As of February 25, 2020, Patrik Olof Dahlén has left the board of directors of LEO PHARMA A/S.
About LEO PHARMA A/S
LEO PHARMA A/S is a Danish company of the type Aktieselskab based in Ballerup, founded in 1962. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named LØVENS KEMISKE FABRIK PRODUKTIONSAKTIESELSKAB. The management consists of Philip Harald Eickhoff and Christophe Dominique Luc Charles Bourdon. The company is owned by LEO Holding A/S and Cidron Savanna 4 SARL. The company has 2,040 employees. In 2025, the company reported revenue of DKK 13,499,000,000 and a net result of DKK 2,489,000,000 compared with DKK -1,776,000,000 the year before. Equity amounted to DKK 5,262,000,000.